Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

20 Drugs That Got Their Start, In Part, With US Public Funding

Executive Summary

The Trump Administration’s budget proposal aims to slash NIH funding that's critical to drug discovery and early research. Here’s a look at 20 of the 213 FDA-approved drugs that benefited from public grants, including IO pioneer Yervoy.

Advertisement

Related Content

Scientists Marched To Protect NIH Grants, But Where Was Pharma?
100% User Fees For US FDA? Trump Budget Revives Important Issue For Industry – But Not This Year
What Medarex Has To Offer At $2.4 Billion

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS120346

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel